| Followers | 2543 |
| Posts | 250735 |
| Boards Moderated | 34 |
| Alias Born | 05/06/2014 |
Sunday, November 26, 2017 1:20:26 PM
The trial will be a two-armed, with approximately 250-patients enrolled and with approximately 125 patients in each arm. It will be conducted in the U.S. with possible study sites in Europe. Currently, we are working on gathering all the items the FDA requires from us before submitting the IND application. Once the IND and clinical trial are approved, we will begin the process of screening patients to participate.
(See pg. 27 of MicroCap Review for our recent feature)
http://www.microcapreview.com/issues/?utm_source=Facebook&utm_campaign=MicroCap
Go $PMCB
investorshub.advfn.com/$Pistol-Pete$-$Mick$-&-Friends-Stock-Picks-29568/
Recent PMCB News
Bantec's Howco Short Term Department of Defense Contract Wins Will Exceed $1,100,000 for the current Quarter • BANT • Jun 25, 2024 10:00 AM
ECGI Holdings Targets $9.7 Billion Equestrian Apparel Market with Allon Brand Launch • ECGI • Jun 25, 2024 8:36 AM
Avant Technologies Addresses Progress on AI Supercomputer-Driven Data Centers • AVAI • Jun 25, 2024 8:00 AM
Green Leaf Innovations, Inc. Expands International Presence with New Partnership in Dubai • GRLF • Jun 24, 2024 8:30 AM
Bemax Inc. Positions to Capitalize on Industry Growth with New Improved Quality of Mother's Touch® Disposable Diapers • BMXC • Jun 24, 2024 8:00 AM
Last Shot Hydration Drink Announced as Official Sponsor of Red River Athletic Conference • EQLB • Jun 20, 2024 2:38 PM
